$10.740
+0.050 (+0.47%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
TLX Prediction & Forecast by Similar Chart Analysis
Alphio's TLX stock price prediction model matches the current Telix Pharmaceuticals Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $11.25 (+0.84%). The 1-week path is $11.66 (+4.50%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Telix Pharmaceuticals Ltd Stock?
Telix Pharmaceuticals is currently not a strong buy due to its low RSI of 39.41, indicating oversold conditions, and a forward P/E ratio of 140.85, suggesting overvaluation. However, the recent FDA approval of Pixclara and the acquisition of ITM for $2.35 billion could drive future growth. The main risk is the high forward P/E, which reflects market skepticism about future earnings growth.
TLX stock price ended at $10.74 on Monday, after rising +0.47%
Telix Pharmaceuticals Ltd (TLX) last closed at $11.16, gaining +3.91%. These facts feed the 1-day and 1-week TLX price prediction above.
Forecast Drivers
Telix Pharmaceuticals Ltd (TLX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches TLX, ranked by similarity.
Seasonality analysis for TLX
Historically the probability of a positive October return for TLX is 37.84%. May offers the highest probability of a positive month at 100.00%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.